Ethosuximide Oral Solution Recalled Due to Lack of CGMP Compliance
PAI Holdings is recalling Ethosuximide Oral Solution 250 mg/5 mL (Lot C9BC, expiration 31 October 2022) distributed nationwide due to potential carry-over contamination from Senna Syrup related to lack of current good manufacturing practices.
- Product
- ETHOSUXIMIDE — ETHOSUXIMIDE (ETHOSUXIMIDE)
- Category
- Drug
- Distribution
- Distributed nationwide